Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
6. GLOBAL ANXIETY DISORDER TREATMENT MARKET, BY DRUG CLASS
6.1. Overview
6.2. SSRIs (Selective Serotonin Reuptake Inhibitors)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4. TCAs (Tricyclic Antidepressants)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.5. Pregabalin
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.6. Buspirone
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.7. Benzodiazepines
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.8. Moclobemide
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.9. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7. GLOBAL ANXIETY DISORDER TREATMENT MARKET, BY END USER
7.1. Overview
7.2. Hospitals
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3. Mental Healthcare Centers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4. Asylums
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.5. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8. GLOBAL ANXIETY DISORDER TREATMENT MARKET, BY REGION
8.1. Overview
8.2. Americas
8.2.1. North America
8.2.1.1. US
8.2.1.2. Canada
8.2.2. Latin America
8.3. Europe
8.3.1. Western Europe
8.3.1.1. Germany
8.3.1.2. France
8.3.1.3. Italy
8.3.1.4. Spain
8.3.1.5. UK
8.3.1.6. Rest of Western Europe
8.3.2. Eastern Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. Rest of Asia-Pacific
8.5. Middle East & Africa
8.5.1. Middle East
8.5.2. Africa
9. COMPANY LANDSCAPE
9.1.1. Overview
9.1.2. Competitive Analysis
10. COMPANY PROFILES
10.1. Eli Lilly and Company
10.1.1. Company Overview
10.1.2. Product Type Overview
10.1.3. Financial Overview
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Forest Laboratories, Inc.
10.2.1. Company Overview
10.2.2. Product Type Overview
10.2.3. Financial Overview
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. AstraZeneca PLC
10.3.1. Company Overview
10.3.2. Product Type Overview
10.3.3. Financial Overview
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Sanofi-Aventis
10.4.1. Company Overview
10.4.2. Product Type Overview
10.4.3. Financial Overview
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Merck & Co., Inc.
10.5.1. Company Overview
10.5.2. Product Type Overview
10.5.3. Financial Overview
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Pfizer, Inc.
10.6.1. Company Overview
10.6.2. Product Type Overview
10.6.3. Financial Overview
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. GlaxoSmithKline PLC
10.7.1. Company Overview
10.7.2. Product Type Overview
10.7.3. Financial Overview
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Johnson & Johnson
10.8.1. Company Overview
10.8.2. Product Type Overview
10.8.3. Financial Overview
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Lundbeck A/S
10.9.1. Company Overview
10.9.2. Product Type Overview
10.9.3. Financial Overview
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Bristol-Myers Squibb Company
10.10.1. Company Overview
10.10.2. Product Type Overview
10.10.3. Financial Overview
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. Others
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL ANXIETY DISORDER TREATMENT MARKET SYNOPSIS, 2020-2027
TABLE 2 GLOBAL ANXIETY DISORDER TREATMENT MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL ANXIETY DISORDER TREATMENT MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL ANXIETY DISORDER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL ANXIETY DISORDER TREATMENT MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 6 NORTH AMERICA: ANXIETY DISORDER TREATMENT MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 7 NORTH AMERICA: ANXIETY DISORDER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 8 US: ANXIETY DISORDER TREATMENT MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 9 US: ANXIETY DISORDER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 10 CANADA: ANXIETY DISORDER TREATMENT MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 11 CANADA: ANXIETY DISORDER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 12 LATIN AMERICA: ANXIETY DISORDER TREATMENT MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 13 LATIN AMERICA: ANXIETY DISORDER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 14 EUROPE: ANXIETY DISORDER TREATMENT MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 15 EUROPE: ANXIETY DISORDER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 16 WESTERN EUROPE: ANXIETY DISORDER TREATMENT MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 17 WESTERN EUROPE: ANXIETY DISORDER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 18 EASTERN EUROPE: ANXIETY DISORDER TREATMENT MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 19 EASTERN EUROPE: ANXIETY DISORDER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 20 ASIA-PACIFIC: ANXIETY DISORDER TREATMENT MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 21 ASIA-PACIFIC: ANXIETY DISORDER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA: ANXIETY DISORDER TREATMENT MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA: ANXIETY DISORDER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ANXIETY DISORDER TREATMENT MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ANXIETY DISORDER TREATMENT MARKET
FIGURE 4 GLOBAL ANXIETY DISORDER TREATMENT MARKET SHARE, BY DRUG CLASS, 2018 (%)
FIGURE 5 GLOBAL ANXIETY DISORDER TREATMENT MARKET SHARE, BY END USER, 2018 (%)
FIGURE 6 GLOBAL ANXIETY DISORDER TREATMENT MARKET SHARE, BY REGION, 2018 (%)
FIGURE 7 AMERICAS: ANXIETY DISORDER TREATMENT MARKET SHARE BY REGION, 2018 (%)
FIGURE 7 NORTH AMERICA: ANXIETY DISORDER TREATMENT MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 8 EUROPE: ANXIETY DISORDER TREATMENT MARKET SHARE, BY REGION, 2018 (%)
FIGURE 9 WESTERN EUROPE: ANXIETY DISORDER TREATMENT MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 10 ASIA-PACIFIC: ANXIETY DISORDER TREATMENT MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 11 MIDDLE EAST & AFRICA: ANXIETY DISORDER TREATMENT MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 12 GLOBAL ANXIETY DISORDER TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2018 (%)
FIGURE 13 ELI LILLY AND COMPANY: KEY FINANCIALS
FIGURE 14 ELI LILLY AND COMPANY: SEGMENTAL REVENUE
FIGURE 15 ELI LILLY AND COMPANY: REGIONAL REVENUE
FIGURE 16 FOREST LABORATORIES, INC.: KEY FINANCIALS
FIGURE 17 FOREST LABORATORIES, INC.: SEGMENTAL REVENUE
FIGURE 18 FOREST LABORATORIES, INC.: REGIONAL REVENUE
FIGURE 19 ASTRAZENECA PLC: KEY FINANCIALS
FIGURE 20 ASTRAZENECA PLC: SEGMENTAL REVENUES
FIGURE 21 ASTRAZENECA PLC: REGIONAL REVENUE
FIGURE 22 SANOFI-AVENTIS: KEY FINANCIALS
FIGURE 23 SANOFI-AVENTIS: SEGMENTAL REVENUE
FIGURE 24 SANOFI-AVENTIS: REGIONAL REVENUE
FIGURE 25 MERCK & CO., INC.: KEY FINANCIALS
FIGURE 26 MERCK & CO., INC.: SEGMENTAL REVENUE
FIGURE 27 MERCK & CO., INC.: REGIONAL REVENUE
FIGURE 28 PFIZER, INC.: KEY FINANCIALS
FIGURE 29 PFIZER, INC.: SEGMENTAL REVENUE
FIGURE 30 PFIZER, INC.: REGIONAL REVENUE
FIGURE 31 GLAXOSMITHKLINE PLC: KEY FINANCIALS
FIGURE 32 GLAXOSMITHKLINE PLC: SEGMENTAL REVENUE
FIGURE 33 GLAXOSMITHKLINE PLC: REGIONAL REVENUE
FIGURE 34 JOHNSON & JOHNSON: KEY FINANCIALS
FIGURE 35 JOHNSON & JOHNSON: SEGMENTAL REVENUE
FIGURE 36 JOHNSON & JOHNSON: REGIONAL REVENUE
FIGURE 37 LUNDBECK A/S: KEY FINANCIALS
FIGURE 38 LUNDBECK A/S SEGMENTAL REVENUE
FIGURE 39 LUNDBECK A/S: REGIONAL REVENUE
FIGURE 40 BRISTOL-MYERS SQUIBB COMPANY: KEY FINANCIALS
FIGURE 41 BRISTOL-MYERS SQUIBB COMPANY: SEGMENTAL REVENUE
FIGURE 42 BRISTOL-MYERS SQUIBB COMPANY: REGIONAL REVENUE
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
